It was said that around 13% of Americans aged 12+ might currently be on #medications to potentially reduce mental disorder symptoms. Also, these other sectors could offer a new way to potentially deal with anxiety for approx. 264M people around the world.
Did you know that to potentially reduce depression symptoms, many people seem to use antibiotics, such as selective serotonin reuptake inhibitors? Check disclaimer on profile and landing page
These other sectors appear to be planning for several clinical trial to potentially address the therapeutic impact of psilocybin and psilocybin analogs on depression in patients with confirmed health predicament-related conditions.